Grey Wolf Health (TSXV:WOLF) Total Stockholders Equity: C$31.74 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSXV:WOLF Grey Wolf Health Corp TSXV:WOLF
56 GF Score
Price C$1.72
GF Value C$1.19
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Grey Wolf Health Total Stockholders Equity?

Grey Wolf Health TSXV:WOLF -0.58% 56 Total Stockholders Equity is C$31.74 Mil as of Jun. 2026. GuruFocus rates TSXV:WOLF with a GF Score™ of 56/100 and a GF Value™ of C$1.19 (Significantly Overvalued). The stock has 5 warning signs investors should review.

Grey Wolf Health's Total Stockholders Equity for the quarter that ended in Jun. 2026 was C$31.74 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Grey Wolf Health's Book Value per Share for the quarter that ended in Jun. 2026 was C$0.92. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Grey Wolf Health's Debt-to-Equity for the quarter that ended in Jun. 2026 was 0.77.

Grey Wolf Health  (TSXV:WOLF) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Grey Wolf Health's Book Value per Share for the quarter that ended in Jun. 2026 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(31.744-0)/34.640
=0.92

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Grey Wolf Health's Debt-to-Equity for the quarter that ended in Jun. 2026 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(2.224 + 22.213) / 31.744
=0.77

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Grey Wolf Health Total Stockholders Equity Related Terms

Grey Wolf Health Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Grey Wolf Health's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Grey Wolf Health Total Stockholders Equity Chart

Grey Wolf Health Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Total Stockholders Equity
4.08 24.25 25.09 28.83 30.57

Grey Wolf Health Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 29.64 30.21 30.57 30.97 31.74
TSXV:WOLF
56GF Score
Grey Wolf Health Corp TSXV:WOLF
Total Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Total Stockholders Equity of C$31.74 Mil mean?
Grey Wolf Health (TSXV:WOLF) has a Total Stockholders Equity of C$31.74 Mil as of Jun. 2026. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Grey Wolf Health and its competitors.
Is Grey Wolf Health's Total Stockholders Equity too high?
Grey Wolf Health's current Total Stockholders Equity is C$31.74 Mil. Overall, Grey Wolf Health has a GF Score™ of 56/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Grey Wolf Health's Total Stockholders Equity compare to competitors?
Grey Wolf Health's Total Stockholders Equity of C$31.74 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Healthcare Providers & Services company?
A good Total Stockholders Equity depends on the Healthcare Providers & Services industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Grey Wolf Health and its competitors. Grey Wolf Health's current Total Stockholders Equity is C$31.74 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Grey Wolf Health stock overvalued right now?
Based on GuruFocus' analysis, Grey Wolf Health (TSXV:WOLF) is currently considered Significantly Overvalued. The stock's GF Value™ is C$1.19, compared to a current price of C$1.72 — trading 44.1% above its estimated fair value. The current Total Stockholders Equity is C$31.74 Mil. Grey Wolf Health's overall GF Score™ is 56/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Grey Wolf Health (TSXV:WOLF), the current Total Stockholders Equity is C$31.74 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Grey Wolf Health (TSXV:WOLF) Overvalued in 2026?

Based on GuruFocus' analysis, Grey Wolf Health stock appears to be overvalued. The current stock price of C$1.72 is trading 44.1% above its estimated GF Value™ of C$1.19. GuruFocus considers Grey Wolf Health to be Significantly Overvalued.

Key valuation signals for TSXV:WOLF:

  • Total Stockholders Equity: C$31.74 Mil
  • GF Value™: C$1.19 vs. price of C$1.72 (44.1% above fair value)
  • GF Score™: 56/100 with 5 warning signs

No single metric tells the full story. See the TSXV:WOLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Grey Wolf Health Business Description

Address 100 King Street West, Suite 6000, 1 First Canadian Place, Toronto, ON, CAN, M5X 1E2
Grey Wolf Animal Health Corp focuses on sourcing, in-licensing, acquiring, and compounding branded and generic products for sale in both animal and human health markets in Canada. The Company operates through two reportable segments: the Animal Health segment, which involves the sale, marketing, and distribution of pharmaceutical, nutraceutical, and consumable products to veterinary clinics across Canada; and the Pharmacy segment, which generates the majority of revenue and focuses on compounding pharmaceuticals for both human and animal health markets.
56GF Score

Get the complete analysis for TSXV:WOLF

Total Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$1.72
Price
C$1.19
GF Value